Display Settings:

Format

Send to:

Choose Destination
    Clin Med Res. 2006 Mar;4(1):79-84.

    Cardiac enzymes, renal failure and renal transplantation.

    Source

    Department of Cardiology, Baskent University Hospital, F. Cakmak Cad. 10.sok, Bahcelievler 06490 Ankara, Turkey. mdhbozbas@yahoo.com

    Abstract

    Diagnostic accuracy of the currently available serum markers of cardiac injury, such as myoglobin, creatine kinase and its myocardial isoform, are altered in patients with renal failure. It is shown that cardiac troponins have decreased diagnostic sensitivity and specificity in patients receiving renal replacement therapy. Data regarding serum levels of these cardiac biomarkers, especially those of the cardiac troponins, in patients with a transplanted kidney are limited. Current data show that levels of cardiac troponin I are unaltered in patients who have undergone renal transplantation, while levels of cardiac troponin T may be elevated.We believe that cardiac troponin I should be the biomarker of choice for diagnosis of myocardial injury in these patients. However, further trials are required for conclusive results.

    PMID:
    16595795
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1435661
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk